Starting Nov. 1, courts, probation and parole officers and community correction managers were able to begin referring eligible felons to designated drug and mental health treatment centers instead of to jail or prison.
Advantage Health Solutions was placed under the supervision of the Indiana Department of Insurance on Friday after the company lost $46.3 million during the first eight months of the year and decided to terminate its Medicare Advantage business.
The 130,000-square-foot building will be designed to encourage collaboration among scientists across different disciplines, which the company said is crucial to fostering innovation.
Companies—including Indiana-based OrthoPediatrics Corp.—are starting to answer parents’ call for more help for children.
Researchers at the Indiana University School of Medicine found that blocking the activity of a key protein can significantly cut down on the graft-versus-host immune response suffered by large numbers of patients who receive stem cell transplants.
Jeff Simmons is on a counteroffensive as, increasingly, the drugs that Elanco makes—including antibiotics and productivity enhancers—have come under attack by food activists.
Sandra is the daughter of Sidney and Lois Eskenazi, the couple who provided a $40 million gift to the Eskenazi Health Capital Campaign and for whom the Eskenazi Health system is named.
The Indiana State Department of Health sent letters to 305,000 parents who haven’t vaccinated their children for a virus known to cause cervical cancer. Conservative groups have objected to what they call an intrusion into parenting decisions.
The Indianapolis-based hospital system announced the donation from John Schnatter Thursday during a groundbreaking ceremony for St. Vincent House, which will include private units for 20 families who have a child or loved receiving extended care.
For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.
The federal penalty for having no health insurance is set to jump to $695, and the Obama administration is being urged to highlight that cold fact to help drive more sign-ups.
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Gov. Mike Pence cited the successes of a $1 million pilot program as reason for granting a new $3.5 million contract to Real Alternatives, a Pennsylvania-based charity.
Long-time health care executive Charles C. Miraglia was picked by the center’s board of directors to replace interim CEO Dan A. Waxman, who has been in that position since January.
William S. Gibbons Jr., Cook's vice president of of global engineering, and his 15-year-old daughter, Abbey, were killed when the plane crashed into Buffalo Mountain in eastern Tennessee.
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
The drugmaker is trying to beef up its work on using the immune system to fight cancer. Indianapolis will remain Lilly’s main hub for research and development.
Dr. Malaz Boustani leads a 26-person team at Eskenazi Health that is showing the group's approach to health care can improve the mental health of both dementia patients and their care givers.
Five months after it expected to hold an election, the union trying to organize nurses at Indiana University Health’s downtown hospitals doesn’t even have a projected date for a vote.
